Condition
Albuminuria clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Albuminuria clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Tanzania (1), Mexico (1)). By phase: Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 5Countries
Newest Albuminuria clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Dapagliflozin to lower albuminuria in adolescents with early chronic kidney disease | Phase 4 | Aguascalientes, Aguascalientes | Recruiting | Feb 12, 2026 |
| Empagliflozin to protect kidney function in sickle cell anemia with albuminuria | Phase 2 | Chicago, Illinois | Recruiting | Sep 16, 2025 |
| Algae supplements for heart risk markers and gut health | — | Porto | Recruiting | Sep 15, 2025 |
| Understanding chronic kidney disease in Sub-Saharan Africa | — | Bagamoyo, Pwani Region | Recruiting | May 31, 2023 |
| Montelukast's effect on kidney and vascular health in type 1 diabetes | Phase 4 | Aurora, Colorado | Recruiting | Aug 11, 2022 |
| Understanding Diabetic Kidney Disease in Patients with Type 2 Diabetes | — | Skejby, Aarhus and 12 other locations | Recruiting | Jun 7, 2021 |
| Understanding pediatric hypertension and its effects on the body | — | Winston-Salem, North Carolina | Recruiting | Feb 12, 2021 |
All recruiting trials (7)
-
Dapagliflozin to lower albuminuria in adolescents with early chronic kidney disease
We will test whether a once-daily 10 mg dapagliflozin pill lowers urine albumin in 14–18-year-olds from Aguascalientes who have early chronic kidney disease and persistent microalbuminuria.
-
Empagliflozin to protect kidney function in sickle cell anemia with albuminuria
This study tests whether taking empagliflozin can slow kidney decline in people with sickle cell anemia and albuminuria.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
-
Understanding chronic kidney disease in Sub-Saharan Africa
This study is trying to understand how common chronic kidney disease is in Sub-Saharan Africa and what factors might be causing it by looking at the health and lifestyle of adults in the Bagamoyo district.
-
Montelukast's effect on kidney and vascular health in type 1 diabetes
This study is testing if the medication montelukast can help improve kidney and heart health in adults with type 1 diabetes who have early signs of kidney problems.
-
Understanding Diabetic Kidney Disease in Patients with Type 2 Diabetes
This study is trying to understand how kidney disease affects people with Type 2 diabetes and macroalbuminuria by looking at their kidney samples and other health markers over 20 years to improve treatment options.
-
Understanding pediatric hypertension and its effects on the body
This study looks at how different factors related to blood pressure affect children aged 7-18 who have just been diagnosed with high blood pressure, to see how it impacts their health over two years.
Related topics
Quick answers
How many Albuminuria clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Tanzania (1 trial), Mexico (1 trial), Portugal (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.